Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Gottesman

Showing results (101-110 of 315) with videos related to

Pageof 32
Sort By:
The Biochemical Journal|December 1, 1987
The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin LR W Mason, S Gal, M M Gottesman
The Biochemical Journal|September 15, 1987
Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsinB R Troen, S Gal, M M Gottesman
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenesM S Rabin, P J Doherty, M M Gottesman
Cancer Research|July 1, 1985
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell linesA Fojo, S Akiyama, M M Gottesman, et al.
Molecular and Cellular Biology|May 1, 1986
Transfer and amplification of a mutant beta-tubulin gene results in colcemid dependence: use of the transformant to demonstrate regulation of beta-tubulin subunit levels by protein degradationC Whitfield, I Abraham, D Ascherman, et al.
Biochimica Et Biophysica Acta|January 9, 1991
Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesiclesM Horio, E Lovelace, I Pastan, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
In vivo drug-selectable genes: a new concept in gene therapyT Licht, F Herrmann, M M Gottesman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastineK Ueda, C Cardarelli, M M Gottesman, et al.
The Journal of Biological Chemistry|June 15, 1986
Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cellsM M Cornwell, M M Gottesman, I H Pastan
Human Gene Therapy|March 21, 2000
Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancersP Hafkemeyer, T Licht, I Pastan, et al.
Pageof 32

Showing results (101-110 of 315) with videos related to

Sort By:
Pageof 32
The Biochemical Journal|December 1, 1987
The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin LR W Mason, S Gal, M M Gottesman
The Biochemical Journal|September 15, 1987
Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsinB R Troen, S Gal, M M Gottesman
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenesM S Rabin, P J Doherty, M M Gottesman
Cancer Research|July 1, 1985
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell linesA Fojo, S Akiyama, M M Gottesman, et al.
Molecular and Cellular Biology|May 1, 1986
Transfer and amplification of a mutant beta-tubulin gene results in colcemid dependence: use of the transformant to demonstrate regulation of beta-tubulin subunit levels by protein degradationC Whitfield, I Abraham, D Ascherman, et al.
Biochimica Et Biophysica Acta|January 9, 1991
Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesiclesM Horio, E Lovelace, I Pastan, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
In vivo drug-selectable genes: a new concept in gene therapyT Licht, F Herrmann, M M Gottesman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastineK Ueda, C Cardarelli, M M Gottesman, et al.
The Journal of Biological Chemistry|June 15, 1986
Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cellsM M Cornwell, M M Gottesman, I H Pastan
Human Gene Therapy|March 21, 2000
Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancersP Hafkemeyer, T Licht, I Pastan, et al.
Pageof 32